Pentoxifylline increases RIF-1 tumour pO2 in a manner compatible with its ability to increase relative tumour perfusion.
暂无分享,去创建一个
[1] R. Jain,et al. Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline. , 1994, British Journal of Cancer.
[2] C. Song,et al. Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline. , 1993, International journal of radiation biology.
[3] J. Lyons,et al. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. , 1992, Radiation research.
[4] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[5] A Ward,et al. Pentoxifylline , 1987, Drugs.
[6] J. Gray,et al. A new mouse tumor model system (RIF-1) for comparison of end-point studies. , 1980, Journal of the National Cancer Institute.
[7] L. Sapirstein,et al. Regional blood flow by fractional distribution of indicators. , 1958, The American journal of physiology.
[8] N. Bleehen,et al. Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice. , 1993, Radiotherapy and Oncology.